Embracing diversity, equity, and inclusion in academic urology: the Young Academic Urologists (YAU) perspective

IF 4.4 2区 医学 Q1 UROLOGY & NEPHROLOGY BJU International Pub Date : 2024-10-15 DOI:10.1111/bju.16549
Rianne J.M. Lammers, Amelia Pietropaolo, Giovanni Cacciamani, Juan Gomez Rivas, Riccardo Campi, Beatriz Bañuelos Marco, All Young Academic Urologists (YAU) Board Members
{"title":"Embracing diversity, equity, and inclusion in academic urology: the Young Academic Urologists (YAU) perspective","authors":"Rianne J.M. Lammers,&nbsp;Amelia Pietropaolo,&nbsp;Giovanni Cacciamani,&nbsp;Juan Gomez Rivas,&nbsp;Riccardo Campi,&nbsp;Beatriz Bañuelos Marco,&nbsp;All Young Academic Urologists (YAU) Board Members","doi":"10.1111/bju.16549","DOIUrl":null,"url":null,"abstract":"<p>The Young Academic Urologists (YAU) is a group of young clinician-scientists (aged &lt;40 years) within the European Association of Urology (EAU) focusing on the development of clinical, educational, and research projects. In particular, due to strategic partnerships with the Guidelines Office, the Sections Office and the European School of Urology (ESU), the goals of YAU are to promote both high-quality studies to provide strong evidence for the best urological practice, and educational programmes to boost European training standards. The aim of creating a platform for close international cooperation for the future urology leaders in Europe (and beyond) is one of the YAU objectives as well. More information is available at: https://uroweb.org/young-academic-urologists-yau.</p><p>The YAU was established as part of the Young Urologists Office (YUO) in 2012, and started with nine working groups (Andrology, Bladder Cancer, Benign Prostatic Hyperplasia, Functional Urology, Paediatric Urology, Prostate Cancer, Renal Cancer, Robotics, and Urolithiasis). Over time, we have grown to 13 groups: Urothelial, Reconstructive, Urotechnology and Digital Health, Endourology and Urolithiasis, Functional Urology, Paediatric Urology, Penile and Testis Cancer, Prostate Cancer, Kidney Transplantation, Renal Cell Carcinoma, Robotic in Urology, Sexual and Reproductive Health, and very recently Infections in Urology. Each group is coordinated by a chairperson, who is actively involved in the YAU Board.</p><p>The YAU members are selected according to their academic career. The YAU groups recently expanded including members of other non-European countries. This is related to the term ‘diversity, equity and inclusion’ (DEI). Diversity refers to the individuals represented in the working force, including gender, ethnicity, religion, and disability. Equity refers to the concept of fairness and justice, e.g., equal access. As such, it is different from equality, which assumes that all people should be treated the same, whereas, with equity the final result will be equal. Lastly, inclusion means that everyone can make meaningful contributions, speak up and all voices will be heard. The YAU groups should therefore include members of different genders, countries, and cultural backgrounds.</p><p>In this research letter, our main objective was to analyse how gender and country representation within the YAU changed over time and we set goals for improvement in the future. Therefore, we collected data regarding member characteristics (gender, country) from 2012 to October 2023 and we stratified them by YAU group. Then, we analysed all papers published by the YAU and checked for gender representation in authorship, by using PubMed with the search code ‘young academic urologist’.</p><p>In the initial period (2012) members were predominantly male (74/78 [95%]), and only a few members came from outside Europe (Appendix A; Fig. A1 and Table A1). During recent years, the situation has gradually improved: currently women constitute 21% of the total number of members (40/191). We also witnessed a rise of interest from non-European members (24/191 [13%] in 2023).</p><p>Groups that deal with oncological topics have more members and thus a higher number of female representations. For example, the Renal Cell Cancer Working Group has a female representation of 29% (six of 21). The highest female representation is in the Paediatric Urology Working Group (five of 10 [50%]) and this group has two generations of female chairs.</p><p>The literature search on YAU publications yielded 396 results. After eliminating duplicates and not-YAU-related articles, we found 344 manuscripts. Considering first and last authorship (in total 688 authorships), 92 of them have female authors (13%). Among the 344 articles, 71 articles (20%) had a female first author, whereas only 21 articles (6%) had a female last author. It is noteworthy to mention that not all YAU articles were coded accurately, thus a possibility of oversight exists; however, the prevailing trend remains evident.</p><p>These numbers needs to be related to EAU membership numbers. Dr Proietti, a member of the EAU DEI task force, wrote a statement article analysing female contributions [<span>1</span>]: in nine European countries 63% of medical students, 48% of all residents, and 24% of all urology consultants, are female. Moreno-Fontela et al. [<span>2</span>] recently analysed Spanish trends and found that 50–61% of the residents were female in 2022.</p><p>Concerning congress activities within the EAU: up until 2021 women presented &lt;20% of all posters, chaired &lt;10% of the scientific sessions, and female faculty representation at congresses was ~12% [<span>1</span>]. The YAU Paediatric Working Group [<span>3</span>] analysed female representation on paediatric urology congresses, which also showed gradual improvement over the years. In the United States the same trends of slowly improving figures are seen [<span>4, 5</span>]. To improve these numbers the EAU DEI task force defined aims and objectives, and a 5–10 year plan with concrete actions. Unfortunately, to date no other work for the EAU DEI task force has emerged.</p><p>Several causes of inequal gender distribution can be pointed out: lack of awareness, limited mentorship opportunities, harassment, disparity regarding promotion opportunities due to e.g., maternity leave, unequal care tasks for women leaving less time left for research compared to men, etc. [<span>4, 5</span>]. This latter may be relevant for the specific case of the YAU working groups: in order to enter YAU the applicant will need to pass a selection, which requires multiple articles in the field of interest. This principle might sometimes benefit male gender.</p><p>Additionally, ‘imposter syndrome’ may play a role. This term, introduced by Clance in 1978, describes a persistent internalised fear of being exposed as frauds. Those individuals experiencing this phenomenon do not believe they deserve their success or luck, regardless of external evidence of their skills. There is scarce literature on imposter syndrome in urologists. According to a large survey done by Jefferson et al. [<span>6</span>] younger and female urologists experience impostor syndrome more severely and it is also independently associated with burnout.</p><p>With the current understanding of the situation, consideration should be given to enhancing DEI within the YAU working groups. Therefore, a ‘Strengths, Weaknesses, Opportunities, and Threats’ (SWOT) analysis is described in Box 1. The DEI criteria are currently being defined and will be published on the YAU website. DEI should be included in the mission of the YAU working groups, including regular evaluation and using it for selecting new members and chairpersons.</p><p>Overall, there is a positive trend in female representation within the YAU working groups; however, numbers are still behind those observed in residency programmes. Several suggestions have been stated. We hope that these efforts raise awareness within the YAU, thus paving the way for further improve in DEI. Our analysis can also encourage other groups to interrogate themselves and improve gender and diversity distributions among their members and board.</p><p>Beatriz Bañuelos Marco: support for congress by Uromune and ITAI.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"135 1","pages":"9-12"},"PeriodicalIF":4.4000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16549","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16549","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Young Academic Urologists (YAU) is a group of young clinician-scientists (aged <40 years) within the European Association of Urology (EAU) focusing on the development of clinical, educational, and research projects. In particular, due to strategic partnerships with the Guidelines Office, the Sections Office and the European School of Urology (ESU), the goals of YAU are to promote both high-quality studies to provide strong evidence for the best urological practice, and educational programmes to boost European training standards. The aim of creating a platform for close international cooperation for the future urology leaders in Europe (and beyond) is one of the YAU objectives as well. More information is available at: https://uroweb.org/young-academic-urologists-yau.

The YAU was established as part of the Young Urologists Office (YUO) in 2012, and started with nine working groups (Andrology, Bladder Cancer, Benign Prostatic Hyperplasia, Functional Urology, Paediatric Urology, Prostate Cancer, Renal Cancer, Robotics, and Urolithiasis). Over time, we have grown to 13 groups: Urothelial, Reconstructive, Urotechnology and Digital Health, Endourology and Urolithiasis, Functional Urology, Paediatric Urology, Penile and Testis Cancer, Prostate Cancer, Kidney Transplantation, Renal Cell Carcinoma, Robotic in Urology, Sexual and Reproductive Health, and very recently Infections in Urology. Each group is coordinated by a chairperson, who is actively involved in the YAU Board.

The YAU members are selected according to their academic career. The YAU groups recently expanded including members of other non-European countries. This is related to the term ‘diversity, equity and inclusion’ (DEI). Diversity refers to the individuals represented in the working force, including gender, ethnicity, religion, and disability. Equity refers to the concept of fairness and justice, e.g., equal access. As such, it is different from equality, which assumes that all people should be treated the same, whereas, with equity the final result will be equal. Lastly, inclusion means that everyone can make meaningful contributions, speak up and all voices will be heard. The YAU groups should therefore include members of different genders, countries, and cultural backgrounds.

In this research letter, our main objective was to analyse how gender and country representation within the YAU changed over time and we set goals for improvement in the future. Therefore, we collected data regarding member characteristics (gender, country) from 2012 to October 2023 and we stratified them by YAU group. Then, we analysed all papers published by the YAU and checked for gender representation in authorship, by using PubMed with the search code ‘young academic urologist’.

In the initial period (2012) members were predominantly male (74/78 [95%]), and only a few members came from outside Europe (Appendix A; Fig. A1 and Table A1). During recent years, the situation has gradually improved: currently women constitute 21% of the total number of members (40/191). We also witnessed a rise of interest from non-European members (24/191 [13%] in 2023).

Groups that deal with oncological topics have more members and thus a higher number of female representations. For example, the Renal Cell Cancer Working Group has a female representation of 29% (six of 21). The highest female representation is in the Paediatric Urology Working Group (five of 10 [50%]) and this group has two generations of female chairs.

The literature search on YAU publications yielded 396 results. After eliminating duplicates and not-YAU-related articles, we found 344 manuscripts. Considering first and last authorship (in total 688 authorships), 92 of them have female authors (13%). Among the 344 articles, 71 articles (20%) had a female first author, whereas only 21 articles (6%) had a female last author. It is noteworthy to mention that not all YAU articles were coded accurately, thus a possibility of oversight exists; however, the prevailing trend remains evident.

These numbers needs to be related to EAU membership numbers. Dr Proietti, a member of the EAU DEI task force, wrote a statement article analysing female contributions [1]: in nine European countries 63% of medical students, 48% of all residents, and 24% of all urology consultants, are female. Moreno-Fontela et al. [2] recently analysed Spanish trends and found that 50–61% of the residents were female in 2022.

Concerning congress activities within the EAU: up until 2021 women presented <20% of all posters, chaired <10% of the scientific sessions, and female faculty representation at congresses was ~12% [1]. The YAU Paediatric Working Group [3] analysed female representation on paediatric urology congresses, which also showed gradual improvement over the years. In the United States the same trends of slowly improving figures are seen [4, 5]. To improve these numbers the EAU DEI task force defined aims and objectives, and a 5–10 year plan with concrete actions. Unfortunately, to date no other work for the EAU DEI task force has emerged.

Several causes of inequal gender distribution can be pointed out: lack of awareness, limited mentorship opportunities, harassment, disparity regarding promotion opportunities due to e.g., maternity leave, unequal care tasks for women leaving less time left for research compared to men, etc. [4, 5]. This latter may be relevant for the specific case of the YAU working groups: in order to enter YAU the applicant will need to pass a selection, which requires multiple articles in the field of interest. This principle might sometimes benefit male gender.

Additionally, ‘imposter syndrome’ may play a role. This term, introduced by Clance in 1978, describes a persistent internalised fear of being exposed as frauds. Those individuals experiencing this phenomenon do not believe they deserve their success or luck, regardless of external evidence of their skills. There is scarce literature on imposter syndrome in urologists. According to a large survey done by Jefferson et al. [6] younger and female urologists experience impostor syndrome more severely and it is also independently associated with burnout.

With the current understanding of the situation, consideration should be given to enhancing DEI within the YAU working groups. Therefore, a ‘Strengths, Weaknesses, Opportunities, and Threats’ (SWOT) analysis is described in Box 1. The DEI criteria are currently being defined and will be published on the YAU website. DEI should be included in the mission of the YAU working groups, including regular evaluation and using it for selecting new members and chairpersons.

Overall, there is a positive trend in female representation within the YAU working groups; however, numbers are still behind those observed in residency programmes. Several suggestions have been stated. We hope that these efforts raise awareness within the YAU, thus paving the way for further improve in DEI. Our analysis can also encourage other groups to interrogate themselves and improve gender and diversity distributions among their members and board.

Beatriz Bañuelos Marco: support for congress by Uromune and ITAI.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在泌尿外科学术领域实现多样性、公平性和包容性:泌尿外科青年学者 (YAU) 的观点。
青年学术泌尿科医师(YAU)是欧洲泌尿科协会(EAU)内的一群年轻的临床科学家(年龄40岁),专注于临床、教育和研究项目的发展。特别是,由于与指南办公室,科办公室和欧洲泌尿外科学院(ESU)的战略伙伴关系,YAU的目标是促进高质量的研究,为最佳泌尿外科实践提供有力的证据,以及提高欧洲培训标准的教育计划。为欧洲(及其他地区)未来的泌尿外科领导者创建一个密切国际合作的平台也是YAU的目标之一。更多信息请访问:https://uroweb.org/young-academic-urologists-yau.The YAU成立于2012年,是青年泌尿科医师办公室(YUO)的一部分,最初有9个工作组(男科、膀胱癌、良性前列腺增生、功能泌尿科、儿科泌尿科、前列腺癌、肾癌、机器人和尿石症)。随着时间的推移,我们已经发展到13个小组:尿路上皮,重建,泌尿技术和数字健康,泌尿内腔和尿石症,功能泌尿外科,儿科泌尿外科,阴茎和睾丸癌,前列腺癌,肾移植,肾细胞癌,泌尿外科机器人,性和生殖健康,以及最近的泌尿外科感染。每个小组由一名主席负责协调,主席积极参与YAU理事会的工作。YAU的成员是根据他们的学术成就选出的。YAU组织最近扩大了,吸纳了其他非欧洲国家的成员。这与“多样性、公平和包容”(DEI)一词有关。多样性是指劳动力中所代表的个体,包括性别、种族、宗教和残疾。公平是指公平和正义的概念,例如,平等的机会。因此,它不同于平等,平等假设所有的人都应该受到同样的对待,而公平最终的结果将是平等的。最后,包容意味着每个人都可以做出有意义的贡献,畅所欲言,所有的声音都会被听到。因此,游友小组应包括不同性别、国家和文化背景的成员。在这封研究信中,我们的主要目标是分析YAU内部的性别和国家代表性如何随着时间的推移而变化,并为未来的改进设定目标。因此,我们收集了2012年至2023年10月成员特征(性别,国家)的数据,并按YAU组进行分层。然后,我们分析了YAU发表的所有论文,并通过PubMed搜索代码“年轻的学术泌尿科医生”来检查作者的性别代表性。在最初阶段(2012年),成员主要是男性(74/78[95%]),只有少数成员来自欧洲以外(附录a;图A1和表A1)。近年来,情况逐渐改善:目前妇女占成员总数的21%(40/191)。我们也见证了非欧洲成员国的兴趣上升(2023年为24/191[13%])。处理肿瘤主题的小组有更多的成员,因此有更多的女性代表。例如,肾细胞癌工作组的女性代表占29%(21人中有6人)。女性比例最高的是儿科泌尿科工作组(5 / 10[50%]),该工作组有两代女性主席。对YAU出版物的文献检索得到396个结果。在排除重复和与youu无关的文章后,我们发现了344篇手稿。考虑到第一作者和最后作者(总共688位作者),其中92位是女性作者(13%)。在344篇文章中,71篇(20%)的第一作者是女性,而只有21篇(6%)的最后作者是女性。值得注意的是,并非所有的YAU文章都是准确编码的,因此存在被监督的可能性;然而,主流趋势仍然很明显。这些数字必须与欧亚联盟成员国的数字相联系。Proietti博士是EAU DEI工作小组的一名成员,他写了一篇分析女性贡献的声明文章:在9个欧洲国家,63%的医科学生、48%的住院医生和24%的泌尿科顾问是女性。Moreno-Fontela等人最近分析了西班牙的趋势,发现到2022年,50-61%的居民是女性。关于欧亚联盟内部的大会活动:截至2021年,女性占所有海报的20%,主持科学会议的10%,女性教师在大会上的代表约为12%。YAU儿科工作小组b[3]分析了女性在儿科泌尿学大会上的代表情况,结果也显示,这些年来女性的代表情况逐渐改善。在美国,也出现了同样缓慢改善的趋势[4,5]。 为了改善这些数字,DEI特别工作组确定了目标和目标,并制定了载有具体行动的5-10年计划。不幸的是,到目前为止,还没有为EAU DEI工作队提出任何其他工作。性别分布不平等的几个原因可以指出:缺乏意识,有限的指导机会,骚扰,晋升机会的差异,如产假,不平等的照顾任务,女性留给研究的时间比男性少,等等[4,5]。后者可能与YAU工作小组的具体情况有关:为了进入YAU,申请人需要通过筛选,这需要在感兴趣的领域发表多篇文章。这一原则有时可能对男性有利。此外,“冒名顶替综合症”也可能起作用。这个词是Clance在1978年提出的,用来描述一种内心深处对被揭露为骗子的持续恐惧。那些经历这种现象的人不相信他们配得上他们的成功或运气,不管他们的技能有什么外在的证据。泌尿科关于冒名顶替综合症的文献很少。根据Jefferson等人所做的一项大型调查,年轻和女性泌尿科医生更容易经历冒名顶替综合症,而且它也与职业倦怠独立相关。根据目前对情况的了解,应考虑在YAU工作小组内加强DEI。因此,“优势,劣势,机会和威胁”(SWOT)分析在框1中描述。DEI的标准目前正在定义,并将在YAU网站上公布。决策评估应列入游友会各工作组的任务,包括定期评价并将其用于选择新成员和主席。总的来说,妇女在游友会工作小组中的代表性呈积极趋势;然而,这一数字仍低于住院医师项目中观察到的数字。提出了几项建议。我们希望这些努力能提高YAU内部的认识,从而为进一步改善DEI铺平道路。我们的分析还可以鼓励其他组织自我审视,并改善其成员和董事会的性别和多样性分布。Beatriz Bañuelos Marco: Uromune和ITAI对国会的支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BJU International
BJU International 医学-泌尿学与肾脏学
CiteScore
9.10
自引率
4.40%
发文量
262
审稿时长
1 months
期刊介绍: BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.
期刊最新文献
The state of urology education in Australia and New Zealand: a regional survey. Response to comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'. Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the ‘External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group’ (EVALUATION-CUETO) study Comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'. The 'Co-Qual': Real-time assessment of prostate biopsy core quality using fluorescence confocal microscopy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1